##gff-version 3
##sequence-region Q13435 1 895
Q13435	UniProtKB	Chain	1	895	.	.	.	ID=PRO_0000174328;Note=Splicing factor 3B subunit 2	
Q13435	UniProtKB	Domain	24	58	.	.	.	Note=SAP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00186	
Q13435	UniProtKB	Region	401	550	.	.	.	Note=Required for interaction with PRMT9;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Coiled coil	140	199	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q13435	UniProtKB	Compositional bias	16	21	.	.	.	Note=Poly-Pro	
Q13435	UniProtKB	Compositional bias	91	96	.	.	.	Note=Poly-Pro	
Q13435	UniProtKB	Compositional bias	104	113	.	.	.	Note=Poly-Pro	
Q13435	UniProtKB	Compositional bias	129	132	.	.	.	Note=Poly-Pro	
Q13435	UniProtKB	Compositional bias	249	253	.	.	.	Note=Poly-Pro	
Q13435	UniProtKB	Compositional bias	292	297	.	.	.	Note=Poly-Glu	
Q13435	UniProtKB	Compositional bias	331	335	.	.	.	Note=Poly-Lys	
Q13435	UniProtKB	Compositional bias	699	702	.	.	.	Note=Poly-Glu	
Q13435	UniProtKB	Compositional bias	720	726	.	.	.	Note=Poly-Glu	
Q13435	UniProtKB	Modified residue	222	222	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q13435	UniProtKB	Modified residue	245	245	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q13435	UniProtKB	Modified residue	247	247	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q13435	UniProtKB	Modified residue	275	275	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q13435	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17525332,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:17525332,PMID:18669648,PMID:23186163	
Q13435	UniProtKB	Modified residue	298	298	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q13435	UniProtKB	Modified residue	307	307	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163	
Q13435	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163	
Q13435	UniProtKB	Modified residue	311	311	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:23186163,PMID:24275569	
Q13435	UniProtKB	Modified residue	317	317	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q13435	UniProtKB	Modified residue	360	360	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q13435	UniProtKB	Modified residue	362	362	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q13435	UniProtKB	Modified residue	431	431	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18318008,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:17081983,PMID:18318008,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q13435	UniProtKB	Modified residue	435	435	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18318008,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:17081983,PMID:18318008,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q13435	UniProtKB	Modified residue	436	436	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18318008,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:17081983,PMID:18318008,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q13435	UniProtKB	Modified residue	508	508	.	.	.	Note=Omega-N-methylarginine%3B by PRMT9%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Modified residue	508	508	.	.	.	Note=Symmetric dimethylarginine%3B by PRMT9%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Modified residue	515	515	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q13435	UniProtKB	Modified residue	780	780	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163	
Q13435	UniProtKB	Modified residue	861	861	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q13435	UniProtKB	Cross-link	10	10	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Cross-link	280	280	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Cross-link	400	400	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25755297,PMID:25772364,PMID:28112733	
Q13435	UniProtKB	Cross-link	412	412	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
Q13435	UniProtKB	Cross-link	492	492	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Cross-link	543	543	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Cross-link	770	770	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Cross-link	790	790	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Cross-link	843	843	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Cross-link	857	857	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13435	UniProtKB	Mutagenesis	471	471	.	.	.	Note=Does not affect methylation by PRMT9. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Mutagenesis	495	495	.	.	.	Note=Does not affect methylation by PRMT9. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Mutagenesis	502	502	.	.	.	Note=Does not affect methylation by PRMT9. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Mutagenesis	506	506	.	.	.	Note=Does not affect methylation by PRMT9%3B when associated with A-510. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25979344;Dbxref=PMID:25979344	
Q13435	UniProtKB	Mutagenesis	507	507	.	.	.	Note=Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine%3B when associated with A-509. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25979344;Dbxref=PMID:25979344	
Q13435	UniProtKB	Mutagenesis	507	507	.	.	.	Note=Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine%3B when associated with R-509. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine%3B when associated with R-508. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine%3B when associated with K-508 and R-509. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25979344;Dbxref=PMID:25979344	
Q13435	UniProtKB	Mutagenesis	508	508	.	.	.	Note=Abolishes interaction with SMN1%3B Abolishes methylation by PRMT9. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine%3B when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine%3B when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine%3B when associated with R-507 and R-509. R->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25737013,ECO:0000269|PubMed:25979344;Dbxref=PMID:25737013,PMID:25979344	
Q13435	UniProtKB	Mutagenesis	509	509	.	.	.	Note=Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine%3B when associated with A-507. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Mutagenesis	509	509	.	.	.	Note=Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine%3B when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine%3B when associated with K-508 and R-507. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Mutagenesis	510	510	.	.	.	Note=Does not affect methylation by PRMT9%3B when associated with A-506. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25979344;Dbxref=PMID:25979344	
Q13435	UniProtKB	Mutagenesis	515	515	.	.	.	Note=Does not affect methylation by PRMT9. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Mutagenesis	530	530	.	.	.	Note=Does not affect methylation by PRMT9. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Mutagenesis	537	537	.	.	.	Note=Does not affect methylation by PRMT9. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25737013;Dbxref=PMID:25737013	
Q13435	UniProtKB	Sequence conflict	602	602	.	.	.	Note=K->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13435	UniProtKB	Sequence conflict	765	765	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13435	UniProtKB	Helix	29	39	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2DO5	
Q13435	UniProtKB	Helix	47	61	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2DO5	
